Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2025)

Kymera Therapeutics (KYMR) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.03 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 41.06% to 0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03 through Dec 2025, down 41.06% year-over-year, with the annual reading at 0.03 for FY2025, 52.43% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.03 at Kymera Therapeutics, down from 0.04 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.14 in Q2 2021, with the low at 0.03 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.09, with a median of 0.09 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 84.72% in 2023, then plummeted 66.43% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.12 in 2021, then plummeted by 35.36% to 0.08 in 2022, then surged by 84.72% to 0.14 in 2023, then tumbled by 66.43% to 0.05 in 2024, then crashed by 41.06% to 0.03 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.03, 0.04, and 0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.